LEVODOPA WITH CARBIDOPA AND ENTACAPONE, Intestinal gel containing levodopa 20 mg with carbidopa monohydrate 5 mg and with entacapone 20 mg per mL, 47 mL, Lecigon®, STADA PHARMACEUTICALS AUSTRALIA PTY LIMITED

№ lp_2_2_05405

File format: docx Character count: 68595 File size: 1369 KB

Year: 2023

Region / city: Australia

Document type: Submission for drug listing

Institution: TGA (Therapeutic Goods Administration)

Author: STADA Pharmaceuticals Australia Pty Ltd

Target audience: Medical practitioners, healthcare professionals, policymakers

Period of validity: Not specified

Approval date: August 29, 2023

Date of amendments: Not specified

Clinical claim: LECIG is non-inferior in terms of efficacy and safety compared to LCIG

Registration status: TGA registered

By placing an order, you agree to the Terms of Use and acknowledge that access to digital materials is provided after payment and is non-refundable, except in cases where the material is not actually accessible.

Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:

Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
In the app, tap Send.
Select network, paste our wallet address.
Send the exact amount shown above.

After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.

Addendum to PBAC November 2024 Meeting on Levodopa with Carbidopa and Entacapone, Intestinal Gel for Parkinson's Disease

Year: 2024

Region / city: Australia

Document Type: Medical Submission

Organization / Institution: PBAC

Author: Not specified

Target audience: Medical practitioners, pharmaceutical authorities

Period of validity: Not specified

Approval date: Not specified

Amendment date: November 2024

Note: Context

Topics: Lecigon STADA Entacapone

Didn’t find what you were looking for?

The project is focused on storing and searching highly specialized data that is rarely indexed by major search engines.

The content of this website is protected under applicable copyright laws, including but not limited to the Copyright Act and relevant legislation of the European Union. Any use of the content, including reproduction, distribution, public communication, modification, or other processing, is prohibited without the prior written consent of the rights holder, unless expressly permitted by law. Users are permitted to use the content solely for personal purposes within the scope defined by copyright legislation. Any other use, including commercial use, requires the prior written authorization of the rights holder. Trademarks, trade names, logos, and other identifiers displayed on this website may be registered trademarks of their respective owners. Any use without the authorization of the relevant rights holder is prohibited. The website operator does not guarantee the accuracy, completeness, or timeliness of the information provided and shall not be liable for any damage or loss resulting from its use, except where required by mandatory legal provisions.

Reproduction of materials is permitted only if a link to speakdot.com is included.